NASDAQ Companies

Phase 1 clinical trial evaluating the off-the-shelf anti-BCMA CAR T candidate CYAD-211 for the treatment of relapsed/refractory multiple myeloma (r/r […]

Beverly Hills, CA, July 13, 2020 (GLOBE NEWSWIRE) — FAT Brands Inc. (Nasdaq: FAT), today announced the pricing of an […]

BRIDGEWATER, N.J., July 13, 2020 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated […]

GAITHERSBURG, Md., July 13, 2020 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the pricing […]

WILMINGTON, N.C., July 13, 2020 (GLOBE NEWSWIRE) — nCino, Inc. (“nCino”) today announced the pricing of its initial public offering […]

LOS ANGELES, July 13, 2020 (GLOBE NEWSWIRE) — Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will […]

MCLEAN, Va., July 13, 2020 (GLOBE NEWSWIRE) — Gladstone Commercial Corporation (Nasdaq: GOOD) (“Gladstone Commercial”) announced today that it has […]

LEIDEN, Netherlands & CAMBRIDGE, Mass., July 13, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives […]

GULFPORT, Miss., July 13, 2020 (GLOBE NEWSWIRE) — Hancock Whitney Corporation (Nasdaq: HWC) will announce second quarter 2020 financial results […]

LA JOLLA, Calif., July 13, 2020 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused […]